• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施美国药典第797章——药物配制-无菌制剂,第5部分:配制制剂的准确性、无菌性和灭菌验证的注意事项。

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.

作者信息

Allen Loyd V, Okeke Claudia C

机构信息

International Journal of Pharmaceutical Compounding, Edmond, Oklahoma.

出版信息

Int J Pharm Compd. 2008 Jan-Feb;12(1):54-60.

PMID:23969573
Abstract

United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations pertains to all preadministration manipulations and procedures involved in the preparation of sterile compounds for application, implantation, infusion, inhalation, injection, insertion, instillation, or irrigation, including preparation, storage, and transportation. The chapter does not pertain to actual clinical administation of compounded sterile preparations to patients. The intent of Chapter 797 is simply to prevent patient harm and fatalitites that may result from nosterility, excessive endotoxin load, large content errors in strength of correct ingredients, or the presence of incorrect ingredients. Because the achievement of sterility requires that facilities meet minimum cleanliness standards, that personnel be trained adequately and undergo periodic testing and training in sterilization techniques, and that appropriate principles and practices be applied to sustain solution stablity, compliance with Chapter 797 should be the goal of any facility where sterile preparations are compounded. Many pharmacies have already achieved compliance with Chapter 797, and those that have already met the new standards seem to support them strongly. This article discusses procedures for verification of the accuracy, sterility, and sterilization of compounded preparations. The importance of United States Pharmacopeia Chapter 71, 1035, and 1211, all of which contain vital information, is also discussed.

摘要

《美国药典》第797章“药物配制 - 无菌制剂”适用于为应用、植入、输注、吸入、注射、插入、滴注或冲洗而制备无菌化合物所涉及的所有给药前操作和程序,包括制备、储存和运输。本章不适用于将配制好的无菌制剂实际临床给药给患者的情况。第797章的目的仅仅是防止因无菌性缺失、内毒素负荷过高、正确成分强度的含量误差过大或存在错误成分而可能导致的患者伤害和死亡。由于实现无菌要求设施符合最低清洁标准,人员接受充分培训并定期接受灭菌技术测试和培训,以及应用适当的原则和实践来维持溶液稳定性,因此遵守第797章应该是任何配制无菌制剂的机构的目标。许多药房已经实现了对第797章的遵守,而且那些已经符合新标准的药房似乎大力支持这些标准。本文讨论了验证配制制剂的准确性、无菌性和灭菌的程序。还讨论了《美国药典》第71章、1035章和1211章的重要性,所有这些章节都包含重要信息。

相似文献

1
Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.实施美国药典第797章——药物配制-无菌制剂,第5部分:配制制剂的准确性、无菌性和灭菌验证的注意事项。
Int J Pharm Compd. 2008 Jan-Feb;12(1):54-60.
2
Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.配制基础:配制人员在实施《美国药典》第797章药物配制——无菌制剂第2部分中的职责。
Int J Pharm Compd. 2007 Jul-Aug;11(4):313-23.
3
Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations.实施美国药典第797章药品配制-无菌制剂,第9部分:立即使用的配制无菌制剂的注意事项。
Int J Pharm Compd. 2008 Sep-Oct;12(5):440-3.
4
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第4部分:消毒剂和防腐剂选择与使用的注意事项
Int J Pharm Compd. 2007 Nov-Dec;11(6):492-9.
5
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797.配制基础:实施美国药典第797章无菌药物制剂配制的注意事项,第6部分:2008年对第797章的修订
Int J Pharm Compd. 2008 Mar-Apr;12(2):136-44.
6
Basics of compounding for the implementation of United States pharmaceopeia chapter 797 pharmaceutical compounding-sterile preparations, part 1.
Int J Pharm Compd. 2007 May-Jun;11(3):230-6.
7
Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparation, part 3: risk levels.
Int J Pharm Compd. 2007 Sep-Oct;11(5):404-10.
8
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第8部分:稳定性和使用期限
Int J Pharm Compd. 2008 Jul-Aug;12(4):344-53.
9
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第15部分:人员培训、清洁与着装
Int J Pharm Compd. 2009 Sep-Oct;11(5):420-6.
10
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 12.配制基础:实施美国药典第797章药物配制-无菌制剂第12部分的注意事项
Int J Pharm Compd. 2009 Mar-Apr;13(2):146-50.